When: Price reclaims $91.50 on daily close with volume ≥5M shares AND MACD histogram flips positive

Then: Scale in 50% of intended add size, then add remainder on hold above $92.00

When: Q3 2026 print: beat with GM expansion and disciplined FY27 input-cost guidance

Then: Upgrade to Overweight at 80-85% of benchmark

When: Q3 2026 print: miss with margin compression and elevated input-cost disclosure

Then: Trim toward Underweight at 70-75% sizing

HOLD - Do not add exposure; wait for confirmed technical signals before scaling in

• CL trades at premium to staples peers: normalized P/E of 26.9x vs PG at 23x and Unilever at 21x
• Operating income down 5.9% YoY in Q2 2026 despite gross margin expansion
• SG&A up 8.5% YoY against 4.9% revenue growth indicates structural cost problem
• Technical breakdown: Sep-04 close at 88.77 broke below Bollinger lower band at 89.06; MACD histogram expanding negative; price below 50 SMA and 10 EMA; VWMA rolled over to 90.96
• 200 SMA at 86.82; if this floor breaks, next support is 80-82 zone
• Aggressive 1:2 setup math flawed: 2.5 points downside to 85.80 vs 4.7 points upside to 93.49 assumes mean reversion which is 'hope not base case'
• Current YTD run of 15.97% means institutional coverage is consistent with stock that already had its move
• Forward P/E of 22.8x faces multiple compression risk in 5% yield environment with 2-year yield at highest since 2025
• Polymarket pricing 93% probability of no Fed cuts in 2026; Iran tail risk at 14% and rising
• Q2 2026 operating income $1.016B roughly flat to slightly declining vs Q2 2025's $1.080B while gross margins expanded - widening gap between gross margin expansion and operating margin compression
• P&G FY27 guidance of 8% core EPS headwind suggests input costs, FX, and financing expense will worsen CL's structural cost problem
• Add trigger should require daily close above 91.73 with MACD histogram flip and RSI >50, not capitulation signal at RSI ≤35 with positive divergence at 200 SMA
• Stop on any new entry should be tightened from 85.80 to 86.30

→ vs aggressive: Normalized P/E of 26.9x still shows CL at premium to PG (23x) and Unilever (21x); forward P/E of 21.6x only reasonable if earnings deliver, but operating income was down 5.9% YoY in Q2 2026

→ vs aggressive: Q4 2025 was a warning shot, not an anomaly; SG&A up 8.5% YoY vs 4.9% revenue growth shows structural cost base expanding faster than top line

→ vs aggressive: 1:2 risk-reward math assumes 86.82 200 SMA holds with high probability, but every short and medium-term moving average is overhead resistance and momentum is accelerating to the downside

→ vs aggressive: If 86.82 floor breaks, next support is 80-82 zone, not 85.80 - making the actual risk-reward roughly 1:1 at best

→ vs aggressive: Institutional consensus as bullish signal is wrong; coverage is consistent with stock that already had its move after 15.97% YTD run

→ vs aggressive: Retail silence is not 'clean entry without froth' - it's a stock with no momentum catalyst, no crowd interest, and no immediate re-rating trigger

→ vs aggressive: Waving away SG&A as 'investment in growth' ignores the trajectory: Q3 2025 $1.059B → Q4 2025 $0.092B → Q1 2026 $0.964B → Q2 2026 $1.016B vs Q2 2025 $1.080B (roughly flat to declining)

→ vs neutral: RSI ≤35 with positive divergence at 200 SMA is a capitulation signal that consumer staples rarely produce; when they do, the underlying reason is usually worse than expected and the bounce often fails

→ vs aggressive: Hawkish Fed with high yields historically leads to dividend aristocrat outperformance over very long periods, but in near-term transition phase with 2-year at generational highs, staples multiples typically compress before re-expanding

Hold core position unchanged. Replace capitulation-style add trigger (RSI ≤35 with positive MACD divergence) with price-zone-plus-momentum-stabilization trigger: test of 86.82 to 87.00 zone with first sign that downside momentum is no longer accelerating. Scale any tactical add at 25 to 33 percent of full sizing. Keep stop at 85.80. Consider long CL / short PG pair trade as alternative expression of bullish view.

• Price sitting below 10 EMA, 50 SMA, Bollinger middle, AND Bollinger lower band; MACD histogram expanding negative; VWAP at 90.96 acting as overhead resistance
• Add trigger zone: 86.82 to 87.00 (200 SMA)
• Stop level: 85.80 (below 200 SMA)
• Tactical add sizing: 25 to 33 percent of planned scale-in allocation
• Remove RSI ≤35 filter as unrealistic for 0.327 beta name
• Valid add triggers: MACD histogram printing less negative than prior day, bullish reversal candle on daily, or reclaim of Bollinger lower band at 89.06 within five sessions
• Scale second tranche above 91.50
• CL is in a margin-investment cycle: spending on Hill's Pet, premium oral care innovation, and emerging markets; one quarter of -5.9% operating income doesn't establish structural break
• Macro headwinds: 5% Treasury yields, Fed priced at 93% no cuts, Iran tail risk at 14%
• Pair trade alternative: long CL / short PG expresses Dividend King coverage differential and hedges FY27 input cost risk

→ vs aggressive: The 1:2 risk-reward math has a hidden assumption that the 200 SMA at 86.82 is a high-probability floor, but all short and medium-term moving averages are aligned bearish; calling a mean-reversion bounce 'the base case' is optimism, not analysis; treating a defensive name like a momentum setup is the error; macro catalyst argument cuts both ways

→ vs conservative: Tightening the stop to 86.30 (below 200 SMA at 86.82) defeats the purpose of using 200 SMA as structural support and causes transaction-cost erosion from being shaken out; requiring RSI above 50 and positive MACD histogram flip before any add is too restrictive and effectively prohibits adding at realistic entry levels